Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 5/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 4/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 4/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL8316642 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL8080341 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL388561 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL18824897 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL995910 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL3258 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL163443 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL3259 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL163442 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL29500208 | 1.00 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | claimed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | claimed |
| US-20150231177-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2015-08-20 | — | — | US | disclosed |
| US-20130289471-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2013-10-31 | — | — | US | disclosed |
| US-20120207793-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2012-08-16 | — | — | US | disclosed |
| US-20120184898-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | TENAX THERAPEUTICS, INC | 2012-07-19 | — | — | US | disclosed |
| US-8101117-B2 | Controlled gas pore formers in extruded ware | CORNING, INCORPORATED (US) | 2012-01-24 | — | — | US | disclosed |
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20090298667-A1 | Controlled Gas Pore Formers in Extruded Ware | CORNING INCORPORATED | 2009-12-03 | — | — | US | disclosed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | disclosed |
| US-20090202617-A1 | Gas based wound and tissue therapeutics | TENAX THERAPEUTICS, INC | 2009-08-13 | — | — | US | disclosed |
| US-20090169630-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2009-07-02 | — | — | US | disclosed |
| CN-101443272-A | Methods and compositions for controlled and sustained generation and delivery of peroxides | UNIV VIRGINIA COMMONWEALTH (US) | 2009-05-27 | — | — | CN | disclosed |
| EP-2024287-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | Virginia Commonwealth University (US) | 2009-02-18 | — | — | EP | disclosed |
| WO-2009006586-A2 | SELF-CONTAINED OXYGEN GENERATING AND BREATHING SYSTEMS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2009-01-08 | — | — | WO | disclosed |
| WO-2007134304-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-11-22 | — | — | WO | disclosed |
| EP-0409612-A1 | Histidine-hydrogen peroxide adduct and process for preparing same | TOKAI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202617-A1 | Gas based wound and tissue therapeutics | PGF, FGF2, FGF1 | SLC7A5 4142/4885CYP3A4 3801/4885CYP1A2 1839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.